Peptonic Medical AB (28L) Stock Price & News

All values in SEK	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	2,58 m	3,54 m	3,14 m	2,36 m
Cost of goods sold	1,44 m	1,37 m	1,02 m	945,00 k
Cost of revenue	1,44 m	1,37 m	1,02 m	945,00 k
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	9,28 m	10,07 m	6,18 m	4,12 m
Operating expense	10,64 m	1,17 m	7,45 m	5,63 m
Total operating expenses	12,08 m	2,54 m	8,47 m	6,58 m
Operating income	-9,50 m	998,00 k	-5,33 m	-4,22 m
Other non operating income	-102,00 k	1,00 k	1,00 k	17,00 k
EBT including unusual items	-11,24 m	-245,00 k	-5,68 m	-3,84 m
EBT excluding unusual items	-11,24 m	-245,00 k	-5,68 m	-4,33 m
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-90,00 k	-10,33 m	-166,00 k	78,00 k
Net income	-11,24 m	-245,00 k	-5,68 m	-3,84 m
Net profit margin	-435,50%	-6,92%	-181,13%	-162,58%
Earnings per share	-	-	-	-
Interest and investment income	-	16,00 k	64,00 k	68,00 k
Interest expense	-1,64 m	-1,26 m	-419,00 k	-194,00 k
Net interest expenses	-1,64 m	-1,24 m	-355,00 k	-126,00 k
Depreciation and amortization charges	1,44 m	1,43 m	1,44 m	1,44 m
EBITDA	-9,01 m	1,48 m	-4,85 m	-3,74 m
Gain or loss from assets sale	-	-	-	-

Ask anything